Identification of Possible Biomarkers in Cardiovascular Diseases
DOI:
https://doi.org/10.12974/2312-5411.2022.09.01Keywords:
Cardiovascular diseases, Atherosclerosis, Risk biomarkersAbstract
Currently, one of the major medical topics researched is the identification in the most diverse diseases, of new molecular biomarkers that would allow the establishment of a positive diagnosis, but also of the response to a certain established treatment (risk biomarkers). Prolonging the lifespan of individuals and increasing the frequency of heart failure from 1-2% in the adult population, regardless of age, to 10-12% in people over 70 explains the worldwide interest in identifying biomarkers and in this condition, regardless of etiology, which offers the possibility of complex assessment of the condition, including the prognosis.
References
Diaconu A, Coculescu BI, Manole G, Vultur H, Coculescu EC, Stocheci CM, Tudorache IS, Dincă AL, Dincă GV. Lipoprotein-associated phospholipase A2 (Lp-PLA2) - possible diagnostic and risk biomarker in chronic ischemic heart disease, J Enzyme Inhib Med Chem 2021; 36(1): 68- 73. https://doi.org/10.1080/14756366.2020.1839447
Coculescu BI, Manole G, Dincă GV, Coculescu EC, Berteanu C, Stocheci CM. Osteopontin - a biomarker of disease, but also of stage stratification of the functional myocardial contractile deficit by chronic ischaemic heart disease, J Enzyme Inhib Med Chem 2019; 34(1): 783-788. https://doi.org/10.1080/14756366.2019.1587418
Coculescu BI, Dincă GV, Bălăeţ C, Manole G, Bălăeţ M, Stocheci CM, Myeloperoxidase, a possible biomarker for the early diagnosis of cardiac diastolic dysfunction with preserved ejection fraction, J Enzyme Inhib Med Chem 2018; 33(1): 1292-1298. https://doi.org/10.1080/14756366.2018.1499626
Coculescu BI, Dincă GV, Manole G, Purcărea VL, Oproiu AM, Stocheci CM. Serum concentration of hsCRP - possible marker for therapy evaluation in left ventricular dysfunction with preserved ejection fraction, Rev de Chimie (Bucharest) 2018; 69(10): 2885-2890. https://doi.org/10.37358/RC.18.10.6646
Coculescu BI, Manole G, Dinca AL, Harsovescu T, Tudorache IS. The possible serum complex-biomarkers for the early diagnosis of diastolic dysfunction with preserved systolic function, Rev. de Chimie (Bucharest) 2019; 70(6): 2229-2231. https://doi.org/10.37358/RC.19.6.7311
Coculescu BI, Harsovescu T, Tudorache IS, Manole G. PON- 1, possible biomarker for diagnosis but also for risk in diastolic dysfunction with preserved ejection fraction, Rev. de Chimie (Bucharest) 2019; 70(4): 1210-1214. https://doi.org/10.37358/RC.19.4.7093
Tudorache SI, Coculescu BI, Manole G, Harsovescu T, Tone MB, Dinca AL. Myeloperoxidase (MPO), possible biomarker in heart failure, Rev. de Chimie (Bucharest), 2019; 70(6): 2173-2176. https://doi.org/10.37358/RC.19.6.7299
Coculescu BI, Dincă GV, Manole G. A novel biomarker in diastolic dysfunction with preserved ejection fraction, Mædica - a Journal of Clinical Medicine, 2019; 14(Suppl): 39.
Coculescu BI, Dincă GV, Manole G. Clinico-biological significance of serum myeloperoxidase in diastolic dysfunction with preserved ejection fraction, 24th Congress of Balkan Military Medical Committee (BMMC), 30 April - 3 May 2019, Tirana, Albania.
